Cargando…
Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy
A goal in cancer therapeutics is to develop targeted modalities that distinguish malignant from normal cells. T cells can discriminate diseased cells based on subtle alterations in peptides displayed in association with MHC molecules at the cell surface. Recent success using the adoptive transfer of...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212006/ https://www.ncbi.nlm.nih.gov/pubmed/15611285 http://dx.doi.org/10.1084/jem.20042004 |
_version_ | 1782148602234142720 |
---|---|
author | Riddell, Stanley R. |
author_facet | Riddell, Stanley R. |
author_sort | Riddell, Stanley R. |
collection | PubMed |
description | A goal in cancer therapeutics is to develop targeted modalities that distinguish malignant from normal cells. T cells can discriminate diseased cells based on subtle alterations in peptides displayed in association with MHC molecules at the cell surface. Recent success using the adoptive transfer of tumor-specific T cells has fueled optimism that this approach may find a place as a targeted therapy for some human cancers. |
format | Text |
id | pubmed-2212006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22120062008-03-11 Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy Riddell, Stanley R. J Exp Med Commentary A goal in cancer therapeutics is to develop targeted modalities that distinguish malignant from normal cells. T cells can discriminate diseased cells based on subtle alterations in peptides displayed in association with MHC molecules at the cell surface. Recent success using the adoptive transfer of tumor-specific T cells has fueled optimism that this approach may find a place as a targeted therapy for some human cancers. The Rockefeller University Press 2004-12-20 /pmc/articles/PMC2212006/ /pubmed/15611285 http://dx.doi.org/10.1084/jem.20042004 Text en Copyright © 2004, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Commentary Riddell, Stanley R. Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy |
title | Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy |
title_full | Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy |
title_fullStr | Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy |
title_full_unstemmed | Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy |
title_short | Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy |
title_sort | finding a place for tumor-specific t cells in targeted cancer therapy |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212006/ https://www.ncbi.nlm.nih.gov/pubmed/15611285 http://dx.doi.org/10.1084/jem.20042004 |
work_keys_str_mv | AT riddellstanleyr findingaplacefortumorspecifictcellsintargetedcancertherapy |